Related Experiment Video

Updated: Jul 14, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

[Pediatric psoriasis]

E Laffitte1, J Izakovic

  • 1Services de dermatologie et vénérologie, CHUV, 101 I Lausanne. emmanuel.laffitte@chuv.ch

Revue Medicale Suisse
|June 8, 2007
PubMed

Insights

Pediatric psoriasis, a chronic inflammatory skin condition, presents diagnostic challenges in children due to atypical lesions. Long-term management and supportive care are crucial for affected children and their families.

Area of Science:

  • Dermatology
  • Pediatrics
  • Immunology

Context:

  • Psoriasis is a chronic inflammatory skin disorder.
  • Pediatric psoriasis can present with atypical or pauci-symptomatic lesions, complicating diagnosis.
  • The prognosis of pediatric psoriasis is often considered worse than atopic dermatitis.

Purpose:

  • To highlight the diagnostic difficulties of pediatric psoriasis.
  • To emphasize the chronic nature and long-term management needs of childhood psoriasis.
  • To underscore the need for more pediatric-specific research on psoriasis treatments.

Summary:

  • Psoriasis in children is a significant cutaneous inflammatory disorder, sometimes presenting in severe forms.
  • Diagnostic challenges arise in pediatric cases due to atypical or subtle initial symptoms.
  • While treatments are similar to adults, they lack extensive pediatric-specific validation.

Impact:

  • Improved understanding of pediatric psoriasis diagnosis and management.
  • Highlights the need for further research into evidence-based pediatric psoriasis therapies.
  • Emphasizes the chronic nature of the disease, requiring long-term patient and family support.

More Related Videos

Measuring Psoriasis Severity at Home02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...